Abstract
Impact of Treatment of Chronic HCV Patients by Direct Acting Antiviral Drugs (DAADs) on COVID -19 Disease Frequency and Severity
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.21608/aeji.2023.210472.1290
Copy DOIPublication Date: Sep 24, 2023 | |
Citations: 1 | License type: cc-by |
Impact of Treatment of Chronic HCV Patients by Direct Acting Antiviral Drugs (DAADs) on COVID -19 Disease Frequency and Severity
Join us for a 30 min session where you can share your feedback and ask us any queries you have